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background:  Little information exists about the anatomic characteristics and clinical relevance of non-infarct related artery (IRA) disease in 
acute ST-segment elevation myocardial infarction (STEMI).
methods: Patients were pooled from 8 independent, international, randomized STEMI clinical trials. Among the 68,765 STEMI patients enrolled in 
the trials, 28,282 patients with valid angiographic information were included in this analysis.
results: Overall, 52.8% (14,929 patients) had obstructive non-IRA disease; 29.6% had 1-vessel and 18.8% had 2-vessel non-IRA disease. There 
was no substantial difference in extent of non-IRA disease according to the IRA territory. Approximately one-third of the patients had obstructive 
disease in each non-IRA territory as opposed to the IRA territories and this pattern was consistent regardless of the IRA location (Figure). Thirty-day 
mortality was higher in patients with non-IRA disease than in those without (4.3% vs. 1.7%). After multivariable adjustment, the presence of non-IRA 
disease was significantly associated with an increase of 30-day mortality (adjusted hazard ratio, 1.79; 95% CI, 1.51 - 2.13).
Conclusions: More than half of the patients with STEMI had obstructive non-IRA disease, which was significantly associated with increased 30-day 
mortality. These findings highlight the need for further research aimed at informing the appropriateness and timing of non-IRA revascularization in 
patients with STEMI.
 
